ANNIBALI, OMBRETTA
 Distribuzione geografica
Continente #
AS - Asia 1.151
NA - Nord America 442
EU - Europa 308
OC - Oceania 7
SA - Sud America 6
AF - Africa 5
Totale 1.919
Nazione #
SG - Singapore 951
US - Stati Uniti d'America 430
CN - Cina 147
IT - Italia 111
GB - Regno Unito 73
FI - Finlandia 26
HK - Hong Kong 24
EE - Estonia 21
DE - Germania 15
NL - Olanda 12
CA - Canada 11
JP - Giappone 11
CZ - Repubblica Ceca 10
FR - Francia 8
AU - Australia 7
IN - India 7
UA - Ucraina 7
ES - Italia 5
ID - Indonesia 5
AT - Austria 3
BR - Brasile 3
CH - Svizzera 3
GR - Grecia 3
ZA - Sudafrica 3
AL - Albania 2
EG - Egitto 2
RS - Serbia 2
TR - Turchia 2
TW - Taiwan 2
AR - Argentina 1
BE - Belgio 1
CL - Cile 1
FK - Isole Falkland (Malvinas) 1
HU - Ungheria 1
IM - Isola di Man 1
KR - Corea 1
MD - Moldavia 1
MX - Messico 1
MY - Malesia 1
RO - Romania 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.919
Città #
Singapore 153
Ashburn 109
Hefei 82
Boardman 74
London 69
Rome 59
Shanghai 43
West Jordan 40
Council Bluffs 28
Los Angeles 26
Helsinki 23
Hong Kong 21
Washington 16
Sona 15
Redmond 13
Seattle 13
Amsterdam 10
San Francisco 10
Brno 9
Santa Clara 9
Toronto 9
Munich 6
St Louis 5
Wuhan 5
Gennevilliers 4
Melbourne 4
Nagoya 4
Pune 4
Athens 3
Canberra 3
Kanazawa 3
Naples 3
Turku 3
Vienna 3
Basel 2
Cairo 2
Charlotte 2
Elbasan 2
Foios 2
Haikou 2
Indore 2
Kragujevac 2
Oklahoma City 2
Senigallia 2
Taipei 2
Tappahannock 2
Tokyo 2
Valencia 2
Andover 1
Ann Arbor 1
Berlin 1
Bhubaneswar 1
Bologna 1
Bratislava 1
Buenos Aires 1
Charleston 1
Chieti 1
Chisinau 1
Ciampino 1
Cleveland 1
Collegeville 1
Costabissara 1
Dorchester 1
Douglas 1
Handan 1
Harbin 1
Hengyang 1
Mexico City 1
Mold 1
New York 1
Newark 1
Padova 1
Paris 1
Prague 1
Puchong Batu Dua Belas 1
Putian 1
Rockville 1
Satu Mare 1
Scottsdale 1
Secaucus 1
Seoul 1
Shenzhen 1
Stockholm 1
São Paulo 1
Tangshan 1
Vancouver 1
Zhengzhou 1
Totale 948
Nome #
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 60
A Feasible Flowchart to Screen EBV-Positive Diffuse Large B Cell Lymphoma of the elderly: A Molecular Approach 57
Early Diastolic Dysfunction after Cancer Chemotherapy: Primary Endpoint Results of a Multicenter Cardio-Oncology Study 50
Being in protective isolation following autologous haematopoietic stem cell transplantation: a phenomenological study 40
A try to positively influence the quality of life of patients undergoing stem cell transplantation in protective isolation with the use of a tablet 40
Artery of Huebner stroke chameleon presenting as central nervous system lymphoma: a case description 38
Protective isolation for patients with haematological malignancies: A pilot study investigating patients’ distress and use of time 38
Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols 38
Acute promyelocytic leukaemia long-term survivors: Higher fatigue and greater overall symptom burden 38
Circulating endothelial cell (CEC) kinetic in patients with Multiple Myeloma (MM) who receive Au-HSCT (Autologous Hematopoietic Stem Cell Transplantation) 37
Sarcopenia Does Not Impact the Outcome of Patients with Multiple Myeloma Consolidated with Autologous Hematopoietic Stem Cell Transplantation 36
Cardiotoxicity of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Pathophysiology, Clinical Implications, and Echocardiographic Assessment 36
PULMONARY FUNCTION TESTS (PFTS) PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANT AS PREDICTOR OF PULMONARY COMPLICATIONS AND SURVIVAL IN ADULTS WITH HEMATOLOGICAL MALIGNANCIES 36
Factors influencing the perception of protective isolation in patients undergoing haematopoietic stem cell transplantation: A multicentre prospective study 36
Impact of IFN lambda 3/4 single nucleotide polymorphisms on the cytomegalovirus reactivation in autologous stem cell transplant patients 36
Tuberculous meningoencephalitis in a patient with hairy cell leukemia in complete remission 36
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 36
Primary cardiac MYC/BCL6 double hit non-Hodgkin lymphoma 35
PD-1/PD-L1 expression in extra-medullary lesions of multiple myeloma 35
Development and initial validation of a questionnaire to assess patients’ perception of protective isolation following haematopoietic stem cell transplantation 35
Central venous catheter infections in patients with malignant hemopathies: report from a single institution 35
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants 35
CD123 is consistently expressed on NPM1-mutated AML cells 35
An integrated system for the monitoring of therapy and drug's side effects in Lymphoproliferative disorders 34
A curious novel combination of nucleophosmin (Npm1) gene mutations leading to aberrant cytoplasmic dislocation of npm1 in acute myeloid leukemia (aml) 34
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial 34
Pharmacology of cardio-oncology: chronotropic and lusitropic effects of B-type natriuretic peptide in cancer patients with early diastolic dysfunction induced by anthracycline or nonanthracycline chemotherapy 33
The endogenous lusitropic and chronotropic agent, B-type natriuretic peptide, limits cardiac troponin release in cancer patients with an early impairment of myocardial relaxation induced by anthracyclines 33
CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL) 33
Neuroradiology of acute pathologies in adults with hematologic malignancies: a pictorial review 32
Wernicke’s Encephalopathy in A Young Adult Affected by T Cell Acute Lymphoblastic Leukemia and Ileotiphlytis with Review of the Literature 32
Emerging from the Darkness. Sudden Cardiac Death in Cardiac Amyloidosis 31
Lung function prior to stem cell transplant as a predictor of infectious and pulmonary complications and survival in adults with haematologic malignancies 31
Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity 31
Pharmacology of Ranolazine versus Common Cardiovascular Drugs in Patients with Early Diastolic Dysfunction Induced by Anthracyclines or Nonanthracycline Chemotherapeutics: A Phase 2b Minitrial 30
Matched-Pair Analysis of Transplant from Haploidentical, Unmanipulated Bone Marrow Donor versus HLA Identical Sibling for Patients with Hematologic Malignancies: Haploidentical vs HLA Identical Transplantation in Hematologic Malignancies 29
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML 28
Che-1/miR-590-3p/TAZ axis sustains multiple myeloma disease 27
PD-1 /PD-L1 checkpoint in hematological malignancies 27
Treatment and prognosis of primary pulmonary lymphoma: A long-term follow-up study 27
Daratumumab in multiple myeloma: experience of the multiple myeloma GIMEMA Lazio group 25
In Ph+BCR-ABL1P210+ acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent 24
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience 24
Trabecular Attenuation of L1 in Adult Patients with Multiple Myeloma: An Observational Study on Low-Dose CT Images 23
IgM-secreting diffuse large B-cell lymphoma: results of a multicentre clinicopathological and molecular study 23
The combination topotecan, temozolomide and dexamethasone associated with radiotherapy as treatment of central nervous system myeloma relapse 23
Pulmonary complications and survival after autologous stem cell transplantation: predictive role of pulmonary function and pneumotoxic medications 23
Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells 22
Autologous stem cell transplantation in multiple myeloma patients over 70 years: A GIMEMA Lazio Working Group experience in a retrospective case–control study 22
IMPACT OF THE IL28B RS12979860 CT POLYMORPHISM ON THE CYTOMEGALOVIRUS REACTIVATION IN AUTOLOGOUS STEM CELL TRANSPLANT PATIENTS 21
KINETICS OF CIRCULATING ENDOTHELIAL CELLS (CECS) DURING AUTOLOGOUS STEM CELLS TRANSPLANTATION (AUSCT) IN PATIENTS WITH MULTIPLE MYELOMA 19
A novel scoring system for TIGIT expression in classic Hodgkin lymphoma 19
Younger age at diagnosis of acute promyelocytic leukaemia is associated with better long-term cognitive functioning 19
Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa 18
Sytemic strongyloidiasis and primary aspergillosis of digestive tract in a patient with T-cell acute lymphoblastic leukemia. 18
Role of the IL28B Rs12979860 C/T Polymorphism on the Incidence of Clinically-Active Cytomegalovirus Infection in Autologous Stem Cell Transplant Patients 17
MiR-22, a serum predictor of poor outcome and therapy response in diffuse large B-cell lymphoma patients 17
Review article: Mucosa-associated lymphoid tissue (MALT)-type lymphoma of ocular adnexa. Biology and treatment. 16
Recurrent Large Volume Silent Strokes in Sickle Cell Disease 15
Prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan and stem cell transplantation: review of the evidence and suggestions 15
Neuroimaging of Acute Conditions in Adult Patients with Haematologic Malignancies: A Pictorial Essay 14
Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy 14
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results 14
Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia 13
Gonadal Function Recovery and Fertility in Women Treated with Chemo- and/or Radiotherapy for Hodgkin's and Non-Hodgkin Lymphoma 12
Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis 12
Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI network 10
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 10
Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study 9
The application of a multidisciplinary approach in the diagnosis of Castleman disease and Castleman‐like lymphadenopathies: A 20‐year retrospective analysis of clinical and pathological features 8
The EASEMENT study: A multicentre, observational, cross-sectional study to evaluate patient preferences, treatment satisfaction, quality of life, and healthcare resource use in patients with multiple myeloma receiving injectable-containing or fully oral therapies 8
Early progression beyond first-line chemoimmunotherapy in follicular lymphoma: Insights from a Fondazione Italiana Linfoma (FIL) study 7
Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi 7
Vaccination strategies for patients with lymphoma treated in early lines of therapies: a real-world practice survey among Fondazione Italiana Linfomi centers 7
Prospective surveillance vs clinically driven approach for CMV reactivation after autologous stem cell transplant. 7
Fertility preservation in lymphoma patients treated with immunochemotherapy regimens with or without radiotherapy: results of a retrospective multicenter Italian study (Ferty care) 7
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma 7
Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials 6
Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatment 6
Effect of daratumumab on stem cell yields in patients with newly diagnosed multiple myeloma: a report from the Multiple Myeloma Group 5
Second Neoplasms in Italian Patients with Hairy Cell Leukemia after Treatment with Cladribine: A Multicenter Investigation and Literature Review 5
Global hemostasis assays in acute myeloid leukemia: results of an observational prospective study 5
Totale 2.020
Categoria #
all - tutte 22.021
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.021


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022162 0 0 1 0 4 1 51 10 4 2 6 83
2022/202396 19 0 0 0 0 1 22 3 4 12 35 0
2023/2024315 22 11 27 19 25 119 7 15 7 46 4 13
2024/20251.447 43 29 104 10 25 66 33 80 205 306 546 0
Totale 2.020